Chlamydia pneumoniae infection and MPO-ANCA-associated glomerulonephritis.
暂无分享，去创建一个
[1] S. Ouellette,et al. Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.
[2] Eresso Aga,et al. Chlamydia pneumoniae Multiply in Neutrophil Granulocytes and Delay Their Spontaneous Apoptosis1 , 2004, The Journal of Immunology.
[3] N. Sera,et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. , 2000, Thyroid : official journal of the American Thyroid Association.
[4] J. Grayston. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. , 2000, The Journal of infectious diseases.
[5] C. Kallenberg. Autoantibodies to myeloperoxidase: clinical and pathophysiological significance , 1998, Journal of Molecular Medicine.
[6] L. Campbell,et al. Chlamydia pneumoniae and cardiovascular disease. , 1997, Emerging infectious diseases.
[7] A. Easton,et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. , 1993, The Journal of infectious diseases.
[8] J. Altman,et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.
[9] A. Ferioli,et al. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. , 1993, Advances in experimental medicine and biology.